We are pleased to announce that we are participating in three upcoming digital health events.
Michele Buenafe, FDA partner and leader of our digital health initiative, will speak at two upcoming FDLI conferences focused on the Food and Drug Administration’s (FDA's) regulation of digital health and developments in digital health regulation before and beyond the coronavirus (COVID-19) pandemic, including significant enforcement discretion policies and exemptions FDA has implemented over the last six months.
- “Is My Digital Health Product a Medical Device?” during the Fundamentals of Digital Health Regulation: Successfully Navigating Your Product Through FDA program on September 9
- “Regulation of Digital Health During and After COVID-19” during the Digital Health Technology and Regulation During COVID-19 and Beyond program on September 10
On our next Fast Break webinar, Jake Harper will discuss updates in telehealth, a topic that has been top of mind for so many healthcare companies amid the COVID-19 pandemic. Register for Fast Break now.
Don’t forget you can check out all of our latest healthcare events and publications on Our Thinking on Healthcare.